Follow-On Products


In addition to IBI-10090, IBI-20089, IBI-60089, and IBI-80090,  IBI is developing clinically superior products to treat a wide variety of ophthalmic diseases including, but not limited to, glaucoma, “wet” Age Related Macular Degeneration (“AMD”), diabetic macular edema, uveitis, cornea transplant rejection, and proliferative diabetic retinopathy.


Icon Bioscience, Inc. | 1253 Reamwood Ave. | Sunnyvale, CA | 94089 | 650-369-4049
Copyright © 2014 Icon Bioscience, Inc. · Optimization by MME ·